Optimal Time for In-situ Dry Needling to Affect the Autonomic Nervous System
1 other identifier
interventional
20
1 country
1
Brief Summary
Assessing for optimal time dry needles need to remain inside the body to have positive effect on the nervous system
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable healthy
Started Sep 2018
Shorter than P25 for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 15, 2018
CompletedFirst Submitted
Initial submission to the registry
October 29, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
October 29, 2018
CompletedFirst Posted
Study publicly available on registry
November 2, 2018
CompletedNovember 2, 2018
October 1, 2018
1 month
October 29, 2018
November 1, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pupil diameter
Change in pupil diameter measured with automated pupillometry device from Micromedical.
1.) 1 minute measure will be taken after accommodation of 2 minutes to the dark environment, 2.) needle placement and an immediate 1 minute second measure, 3.) every 2 minutes a measure of 1 minute to 8 post needle measures (24 minutes) total
Study Arms (1)
study group
EXPERIMENTALStudy group receiving dry needling and pupil diameter will be studied up to 23 minutes after needle placement.
Interventions
Eligibility Criteria
You may qualify if:
- Age between 18-65 years old
- No pain at all anywhere in the body at the time of testing.
- No caffeine containing products 3 hours before measurement and no use of over the counter Non-Steroidal Anti-Inflammatory Drug (NSAID) before the testing.
You may not qualify if:
- Red flags identified during the subjects intake. If needling is contraindicated the subjects will be removed from the study and if necessary will be referred to an appropriate health care provider.
- Use of blood thinners
- History of surgery and or injury within the past six weeks
- Evidence of central nervous system involvement, to include hyperreflexia, sensory disturbances in the hand, intrinsic muscle wasting of the hands, unsteadiness during walking, nystagmus, loss of visual acuity, impaired sensation of the face, altered taste, the presence of pathological reflexes (i.e. positive Hoffman's and/or Babinski reflexes), etc.
- Prior surgery to the neck or thoracic spine
- Chiropractic, Physical Therapy, Dry needling or Acupuncture treatment for their neck pain in the last 3-months
- Inability to follow directions and keep the eye open during the measurement phase of this study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Integrated Therapy Practice PC
Hobart, Indiana, 46342, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rob Sillevis, PhD
Faculty
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 29, 2018
First Posted
November 2, 2018
Study Start
September 1, 2018
Primary Completion
October 15, 2018
Study Completion
October 29, 2018
Last Updated
November 2, 2018
Record last verified: 2018-10
Data Sharing
- IPD Sharing
- Will not share